OCUL
Ocular TherapeutixCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
OCUL vs peer average
53/100
OCUL vs. peer average (C vs. C)
Grade spread
B 3 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
KALA is the first available peer comparator.
Kala Pharmaceuticals — specialty ophthalmic developer; comparable commercial execution and reimbursement sensitivity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OCUL
Ocular Therapeutix
KALA
KALA BIO
Grade
C
F
Momentum
37
39
Value
41
41
Sentiment
83
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs KALA
OCUL / KALA
Grade Position
In line
OCUL vs. peer average (C vs. C)
53/100
Momentum
37
KALAValue
41
OCULSentiment
83
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OCUL
KALA is the first peer returned for this comparison set.